"
Predictive Factors of Intracranial Response of Immune Checkpoint Inhibitors in Patients with Brain Metastasis from Non-Small Cell Lung Cancer"
written by Julien Bermudez, Celine Mascaux, Youssef Trigui, Julie Biemar, Mohamed Boucekine, Laurent Greillier, Fabrice Barlesi, Pascale Tomasini,
published by
Journal of Cancer Therapy,
Vol.10 No.8, 2019
has been cited by the following article(s):
|
[1]
|
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
Lung Cancer,
2022
DOI:10.1016/j.lungcan.2022.05.004
|
|
|
|
|
[2]
|
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcome
Lung Cancer,
2022
DOI:10.1016/j.lungcan.2022.05.004
|
|
|
|